DavisLLEnglishBAAmbroseSM, and others. Pharmacotherapy for post-traumatic stress disorder: A comprehensive review. Expert Opin Pharmacother2001;2:1583–95.
2.
KhouzamHRDonellyNJ. Post-traumatic stress disorder. Safe, effective management in the primary care setting. Postgrad Med2001;110:67–70,77–8.
3.
HamnerMBLabbateLA. Pharmacotherapy of post-traumatic stress disorder. Inter Drug Ther News2002;37:33–9.
4.
SernyakMJKostenTRFontanaA, and others. Neuroleptic use in the treatment of post-traumatic stress disorder. Psychiatr Q2001;72:197–213.
5.
KrashinDOatesEW. Risperidone as an adjunct therapy for post-traumatic stress disorder. Mil Med1999;164:605–6.
6.
EidelmanISeedatSSteinDJ. Risperidone in the treatment of acute stress disorder in physically traumatized in-patients. Depress Anxiety2000;11:187–8.
7.
LeybaCMWamplerTP. Risperidone in PTSD. Psych Serv1998;49:245–6.
8.
MonnellyEpCirauloDA. Risperidone effects on irritable aggression in post-traumatic stress disorder. J Clin Psychopharmacol1999;19:377–8.
9.
HamnerMBUlmerHGFaldowskiRA, and others. A randomized controlled trial of risperidone for psychotic features in PTSD. Neuropsychopharmacol2000;23:(Suppl 120).
10.
ButterfieldMIBeckerMEConnorKM, and others. Olanzapine in the treatment of post-traumatic stress disorder: A pilot study. Int Clin Psychopharmacol2001;16:197–203.
11.
PettyFBrannanSCasadaJ, and others. Olanzapine treatment for post-traumatic stress disorder: An open-label study. Int Clin Psychopharmacol2001;16:331–7.
12.
HamnerMB. Clozapine treatment for a veteran with comorbid psychosis and PTSD. Am J Psychiatry1996;153:841.
13.
HamnerMBDeitschSEBrodrickPS, and others. Quetiapine treatment in PTSD: An open trial of adjunctive therapy. J Clin Psychopharmacol (Forthcoming).